Published in EMBO J on July 17, 1995
Cellular origin and ultrastructure of membranes induced during poliovirus infection. J Virol (1996) 4.41
Open reading frame 1a-encoded subunits of the arterivirus replicase induce endoplasmic reticulum-derived double-membrane vesicles which carry the viral replication complex. J Virol (1999) 3.51
Formation of the poliovirus replication complex requires coupled viral translation, vesicle production, and viral RNA synthesis. J Virol (2000) 2.13
Coxsackievirus protein 2B modifies endoplasmic reticulum membrane and plasma membrane permeability and facilitates virus release. EMBO J (1997) 2.09
Genetic map of the calicivirus rabbit hemorrhagic disease virus as deduced from in vitro translation studies. J Virol (1996) 1.82
Isolation of enzymatically active replication complexes from feline calicivirus-infected cells. J Virol (2002) 1.67
Genetic analysis of the yellow fever virus NS1 protein: identification of a temperature-sensitive mutation which blocks RNA accumulation. J Virol (1997) 1.65
Viroporins: structure and biological functions. Nat Rev Microbiol (2012) 1.56
Processing of the equine arteritis virus replicase ORF1b protein: identification of cleavage products containing the putative viral polymerase and helicase domains. J Virol (1996) 1.53
Cowpea mosaic virus infection induces a massive proliferation of endoplasmic reticulum but not Golgi membranes and is dependent on de novo membrane synthesis. J Virol (2000) 1.53
Role of microtubules in extracellular release of poliovirus. J Virol (2009) 1.49
Poliovirus proteins induce membrane association of GTPase ADP-ribosylation factor. J Virol (2005) 1.47
Poliovirus protein 3A inhibits tumor necrosis factor (TNF)-induced apoptosis by eliminating the TNF receptor from the cell surface. J Virol (2001) 1.39
Poliovirus infection and expression of the poliovirus protein 2B provoke the disassembly of the Golgi complex, the organelle target for the antipoliovirus drug Ro-090179. J Virol (1997) 1.37
Brefeldin A inhibits cell-free, de novo synthesis of poliovirus. J Virol (1998) 1.35
A cysteine-rich motif in poliovirus protein 2C(ATPase) is involved in RNA replication and binds zinc in vitro. J Virol (2000) 1.35
Amino acid changes in proteins 2B and 3A mediate rhinovirus type 39 growth in mouse cells. J Virol (2005) 1.25
Membrane permeabilization by small hydrophobic nonstructural proteins of Japanese encephalitis virus. J Virol (1999) 1.25
Viral and host proteins involved in picornavirus life cycle. J Biomed Sci (2009) 1.24
Changes in rhinovirus protein 2C allow efficient replication in mouse cells. J Virol (2003) 1.23
Multifaceted roles for lipids in viral infection. Trends Microbiol (2011) 1.22
The transformation of enterovirus replication structures: a three-dimensional study of single- and double-membrane compartments. MBio (2011) 1.21
Turnip mosaic virus RNA replication complex vesicles are mobile, align with microfilaments, and are each derived from a single viral genome. J Virol (2009) 1.20
Grapevine fanleaf virus replication occurs on endoplasmic reticulum-derived membranes. J Virol (2002) 1.15
Poliovirus protein 2BC increases cytosolic free calcium concentrations. J Virol (1997) 1.09
Cowpea mosaic virus 32- and 60-kilodalton replication proteins target and change the morphology of endoplasmic reticulum membranes. J Virol (2002) 1.05
A protein linkage map of the P2 nonstructural proteins of poliovirus. J Virol (1998) 1.05
Identification of regions of poliovirus 2BC protein that are involved in cytotoxicity. J Virol (1998) 1.02
A stable HeLa cell line that inducibly expresses poliovirus 2A(pro): effects on cellular and viral gene expression. J Virol (2000) 0.98
Coxsackievirus B3 proteins directionally complement each other to downregulate surface major histocompatibility complex class I. J Virol (2007) 0.97
Initiation of poliovirus negative-strand RNA synthesis requires precursor forms of p2 proteins. J Virol (2003) 0.94
Foot-and-mouth disease virus, but not bovine enterovirus, targets the host cell cytoskeleton via the nonstructural protein 3Cpro. J Virol (2008) 0.93
Sindbis virus variant with a deletion in the 6K gene shows defects in glycoprotein processing and trafficking: lack of complementation by a wild-type 6K gene in trans. J Virol (2001) 0.93
Insight into poliovirus genome replication and encapsidation obtained from studies of 3B-3C cleavage site mutants. J Virol (2009) 0.93
Membrane integration of poliovirus 2B viroporin. J Virol (2011) 0.91
Replication and Inhibitors of Enteroviruses and Parechoviruses. Viruses (2015) 0.89
Intracellular topology and epitope shielding of poliovirus 3A protein. J Virol (2004) 0.87
Mutations in the 2C region of poliovirus responsible for altered sensitivity to benzimidazole derivatives. J Virol (2000) 0.86
Translation without eIF2 promoted by poliovirus 2A protease. PLoS One (2011) 0.85
Mutagenesis of the coxsackie B3 virus 2B/2C cleavage site: determinants of processing efficiency and effects on viral replication. J Virol (1996) 0.84
Translation directed by hepatitis A virus IRES in the absence of active eIF4F complex and eIF2. PLoS One (2012) 0.83
Poliovirus-induced changes in cellular membranes throughout infection. Curr Opin Virol (2014) 0.83
Recombinant Dengue virus protein NS2B alters membrane permeability in different membrane models. Virol J (2016) 0.82
Human rhinovirus 16 causes Golgi apparatus fragmentation without blocking protein secretion. J Virol (2014) 0.80
Viroporins customize host cells for efficient viral propagation. DNA Cell Biol (2013) 0.78
Enterovirus infection of human islets of Langerhans affects β-cell function resulting in disintegrated islets, decreased glucose stimulated insulin secretion and loss of Golgi structure. BMJ Open Diabetes Res Care (2016) 0.76
Impact of Vesicular Stomatitis Virus M Proteins on Different Cellular Functions. PLoS One (2015) 0.75
UGGT1 enhances enterovirus 71 pathogenicity by promoting viral RNA synthesis and viral replication. PLoS Pathog (2017) 0.75
Identification of 23 complementation groups required for post-translational events in the yeast secretory pathway. Cell (1980) 23.17
Biosynthetic protein transport and sorting by the endoplasmic reticulum and Golgi. Annu Rev Biochem (1987) 10.25
Distinct sets of SEC genes govern transport vesicle formation and fusion early in the secretory pathway. Cell (1990) 8.98
KAR2, a karyogamy gene, is the yeast homolog of the mammalian BiP/GRP78 gene. Cell (1989) 8.14
Product review. New mammalian expression vectors. Nature (1990) 7.97
Genetics of poliovirus. Annu Rev Genet (1993) 7.41
Two nuclear mutations that block mitochondrial protein import in yeast. Proc Natl Acad Sci U S A (1984) 7.39
Molecular dissection of the secretory pathway. Nature (1992) 7.38
Glycosylation and processing of prepro-alpha-factor through the yeast secretory pathway. Cell (1984) 5.53
Aminopeptidase I of Saccharomyces cerevisiae is localized to the vacuole independent of the secretory pathway. J Cell Biol (1992) 5.50
Vesicle-mediated protein sorting. Annu Rev Biochem (1992) 5.20
GTP-binding domain: three consensus sequence elements with distinct spacing. Proc Natl Acad Sci U S A (1987) 5.16
Organelle assembly in yeast: characterization of yeast mutants defective in vacuolar biogenesis and protein sorting. J Cell Biol (1988) 4.90
Methods for studying the yeast vacuole. Methods Enzymol (1991) 4.55
Assembly of vaccinia virus: role of the intermediate compartment between the endoplasmic reticulum and the Golgi stacks. J Cell Biol (1993) 4.34
ELECTRON MICROSCOPIC STUDY OF THE FORMATION OF POLIOVIRUS. Virology (1965) 3.71
Structural and functional characterization of the poliovirus replication complex. J Virol (1992) 3.70
Genetic complementation among poliovirus mutants derived from an infectious cDNA clone. J Virol (1986) 3.65
The Saccharomyces cerevisiae SEC14 gene encodes a cytosolic factor that is required for transport of secretory proteins from the yeast Golgi complex. J Cell Biol (1989) 3.55
Membrane rearrangement and vesicle induction by recombinant poliovirus 2C and 2BC in human cells. Virology (1994) 3.52
Increased amounts of HMG-CoA reductase induce "karmellae": a proliferation of stacked membrane pairs surrounding the yeast nucleus. J Cell Biol (1988) 3.04
Inhibition of poliovirus RNA synthesis by brefeldin A. J Virol (1992) 2.96
Intracellular distribution of poliovirus proteins and the induction of virus-specific cytoplasmic structures. Virology (1983) 2.79
The dynamic nature of the Golgi complex. J Cell Biol (1989) 2.61
The ras-like yeast YPT1 gene is itself essential for growth, sporulation, and starvation response. Mol Cell Biol (1987) 2.58
The VPS16 gene product associates with a sedimentable protein complex and is essential for vacuolar protein sorting in yeast. J Biol Chem (1993) 2.50
Poliovirus protein 2C has ATPase and GTPase activities. J Biol Chem (1993) 2.32
Membranous structures associated with translation and transcription of poliovirus RNA. Science (1969) 2.21
Association of the polioviral RNA polymerase complex with phospholipid membranes. J Virol (1976) 2.14
Modification of membrane permeability by animal viruses. Adv Virus Res (1995) 2.11
Induction of membrane proliferation by poliovirus proteins 2C and 2BC. Biochem Biophys Res Commun (1995) 2.03
A novel pathway of import of alpha-mannosidase, a marker enzyme of vacuolar membrane, in Saccharomyces cerevisiae. J Biol Chem (1990) 1.94
Phospholipid biosynthesis and poliovirus genome replication, two coupled phenomena. EMBO J (1990) 1.88
Poliovirus protein 2C contains two regions involved in RNA binding activity. J Biol Chem (1995) 1.74
Physical interaction of the HIV-1 Nef protein with beta-COP, a component of non-clathrin-coated vesicles essential for membrane traffic. J Biol Chem (1994) 1.68
Antagonistic controls regulate copy number of the yeast 2 mu plasmid. EMBO J (1987) 1.66
An intragenic revertant of a poliovirus 2C mutant has an uncoating defect. J Virol (1990) 1.62
Brefeldin A reversibly blocks early but not late protein transport steps in the yeast secretory pathway. EMBO J (1993) 1.59
Association of poliovirus proteins with the endoplasmic reticulum. J Virol (1984) 1.57
Human p53 and CDC2Hs genes combine to inhibit the proliferation of Saccharomyces cerevisiae. Mol Cell Biol (1992) 1.55
Intracellular localization of poliovirus RNA by in situ hybridization at the ultrastructural level using single-stranded riboprobes. Virology (1992) 1.49
Studies of a putative amphipathic helix in the N-terminus of poliovirus protein 2C. Virology (1994) 1.43
Proteins involved in vesicular transport and membrane fusion. Curr Opin Cell Biol (1991) 1.14
Poliovirus genetics. Curr Top Microbiol Immunol (1990) 1.10
A poliovirus minireplicon containing an inactive 2A proteinase is expressed in vaccinia virus-infected cells. J Virol (1993) 1.07
Brefeldin A blocks protein glycosylation and RNA replication of vesicular stomatitis virus. FEBS Lett (1993) 0.93
Cloning of the orotidine 5'-phosphate decarboxylase (ODC) gene of Schwanniomyces occidentalis by complementation of the ura3 mutation in S. cerevisiae. Curr Genet (1988) 0.86
Hybrid proteins between Pseudomonas exotoxin A and poliovirus protease 2Apro. FEBS Lett (1994) 0.85
Retracted Expression of p60v-src in Saccharomyces cerevisiae results in elevation of p34CDC28 kinase activity and release of the dependence of DNA replication on mitosis. Mol Cell Biol (1993) 0.83
Cloning and inducible synthesis of poliovirus non-structural proteins in Saccharomyces cerevisiae. Gene (1995) 0.77
Eukaryotic translation initiation factor 4GI is a cellular target for NS1 protein, a translational activator of influenza virus. Mol Cell Biol (2000) 2.48
The trichodermin group of antibiotics, inhibitors of peptide bond formation by eukaryotic ribosomes. Biochim Biophys Acta (1973) 2.36
Poliovirus protein 2C has ATPase and GTPase activities. J Biol Chem (1993) 2.32
Involvement of membrane traffic in the replication of poliovirus genomes: effects of brefeldin A. Virology (1992) 2.18
Sodium ions and the shut-off of host cell protein synthesis by picornaviruses. Nature (1977) 2.12
Involvement of the vacuolar H(+)-ATPase in animal virus entry. J Gen Virol (1994) 2.06
Entry of poliovirus into cells does not require a low-pH step. J Virol (1993) 2.05
Viral infection permeabilizes mammalian cells to protein toxins. Cell (1980) 2.04
Induction of membrane proliferation by poliovirus proteins 2C and 2BC. Biochem Biophys Res Commun (1995) 2.03
Phospholipid biosynthesis and poliovirus genome replication, two coupled phenomena. EMBO J (1990) 1.88
Requirement for vacuolar proton-ATPase activity during entry of influenza virus into cells. J Virol (1995) 1.77
Poliovirus protein 2C contains two regions involved in RNA binding activity. J Biol Chem (1995) 1.74
Human gamma interferon and tumor necrosis factor exert a synergistic blockade on the replication of herpes simplex virus. J Virol (1989) 1.71
Lack of direct correlation between p220 cleavage and the shut-off of host translation after poliovirus infection. Virology (1992) 1.57
Ribosome inactivation by the toxic lectins abrin and ricin. Kinetics of the enzymic activity of the toxin A-chains. Eur J Biochem (1975) 1.54
Membrane permeabilization by poliovirus proteins 2B and 2BC. J Biol Chem (1996) 1.51
Membrane leakiness after viral infection and a new approach to the development of antiviral agents. Nature (1978) 1.46
Vagal system involvement in changes in small bowel motility during restraint stress: an experimental study in the dog. Br J Surg (1993) 1.46
Poliovirus infection and expression of the poliovirus protein 2B provoke the disassembly of the Golgi complex, the organelle target for the antipoliovirus drug Ro-090179. J Virol (1997) 1.37
Expression of poliovirus nonstructural proteins in Escherichia coli cells. Modification of membrane permeability induced by 2B and 3A. J Biol Chem (1992) 1.35
Membrane permeability changes induced in Escherichia coli by the SH protein of human respiratory syncytial virus. Virology (1997) 1.31
Polysaccharides as antiviral agents: antiviral activity of carrageenan. Antimicrob Agents Chemother (1987) 1.31
Proteins are cointernalized with virion particles during early infection. Virology (1987) 1.30
HIV-1 protease cleaves eukaryotic initiation factor 4G and inhibits cap-dependent translation. Proc Natl Acad Sci U S A (2001) 1.30
Efficient cleavage of p220 by poliovirus 2Apro expression in mammalian cells: effects on vaccinia virus. Biochem Biophys Res Commun (1995) 1.29
Monensin and nigericin prevent the inhibition of host translation by poliovirus, without affecting p220 cleavage. J Virol (1995) 1.28
The inhibition of cell functions after viral infection. A proposed general mechanism. FEBS Lett (1977) 1.27
The entry of reovirus into L cells is dependent on vacuolar proton-ATPase activity. J Virol (1996) 1.24
Genetic analysis of poliovirus protein 3A: characterization of a non-cytopathic mutant virus defective in killing Vero cells. J Gen Virol (1998) 1.22
3-Methylquercetin is a potent and selective inhibitor of poliovirus RNA synthesis. Virology (1986) 1.22
Semliki Forest virus 6K protein modifies membrane permeability after inducible expression in Escherichia coli cells. J Biol Chem (1994) 1.21
Modification of membrane permeability induced by animal viruses early in infection. Virology (1981) 1.19
Ribavirin cures cells of a persistent infection with foot-and-mouth disease virus in vitro. J Virol (1987) 1.18
Enhanced intracellular calcium concentration during poliovirus infection. J Virol (1995) 1.18
Synthesis of Semliki Forest virus RNA requires continuous lipid synthesis. Virology (1991) 1.17
Initiation of the polypeptide chain by reticulocyte cell-free systems. Survey of different inhibitors of translation. Eur J Biochem (1976) 1.15
Poliovirus protease 3C(pro) kills cells by apoptosis. Virology (2000) 1.13
Tuberculosis transmission risk and infection control in a hospital emergency department in Lima, Peru. Int J Tuberc Lung Dis (2010) 1.11
Thionins: plant peptides that modify membrane permeability in cultured mammalian cells. Eur J Biochem (1981) 1.10
Degradation of cellular proteins during poliovirus infection: studies by two-dimensional gel electrophoresis. J Virol (1989) 1.09
Gliotoxin: inhibitor of poliovirus RNA synthesis that blocks the viral RNA polymerase 3Dpol. J Virol (1992) 1.09
Poliovirus protein 2BC increases cytosolic free calcium concentrations. J Virol (1997) 1.09
Inhibition of animal virus production by means of translation inhibitors unable to penetrate normal cells. Virology (1980) 1.08
Relationship between membrane integrity and the inhibition of host translation in virus-infected mammalian cells. Comparative studies between encephalomyocarditis virus and poliovirus. Eur J Biochem (1982) 1.08
Molecular basis of the permeabilization of mammalian cells by ionophores. Eur J Biochem (1982) 1.08
Early platelet aggregation as a cause of thrombocytopenia in classical swine fever. Vet Pathol (2002) 1.08
Poliovirus 2A proteinase cleaves directly the eIF-4G subunit of eIF-4F complex. FEBS Lett (1998) 1.07
Selective inhibition of protein synthesis in virus-infected mammalian cells. J Virol (1979) 1.07
Modification of membrane permeability in vaccinia virus-infected cells. Virology (1982) 1.06
Enzymic and nonenzymic translocation by yeast polysomes. Site of action of a number of inhibitors. Biochemistry (1977) 1.05
Synthesis of heat-shock proteins in HeLa cells: inhibition by virus infection. Virology (1984) 1.03
Mutational analysis of poliovirus 2Apro. Distinct inhibitory functions of 2apro on translation and transcription. J Biol Chem (1998) 1.03
The amino-terminal nine amino acid sequence of poliovirus capsid VP4 protein is sufficient to confer N-myristoylation and targeting to detergent-insoluble membranes. Biochemistry (2000) 1.03
Identification of regions of poliovirus 2BC protein that are involved in cytotoxicity. J Virol (1998) 1.02
Formation of non-infective herpesvirus particles in cultured cells treated with human interferon. J Gen Virol (1984) 1.02
A novel mutation (G114V) in the prion protein gene in a family with inherited prion disease. Neurology (2005) 1.01
Influenza virus M2 protein modifies membrane permeability in E. coli cells. FEBS Lett (1994) 1.01
The human immunodeficiency virus type 1 Vpu protein enhances membrane permeability. Biochemistry (1998) 1.01
Cation content in poliovirus-infected HeLa cells. J Gen Virol (1987) 1.01
Endogenous lipid pneumonia in a dog. J Comp Pathol (2006) 1.00
Action of human lymphoblastoid interferon on HeLa cells infected with RNA-containing animal viruses. J Gen Virol (1984) 1.00
Narciclasine: an antitumour alkaloid which blocks peptide bond formation by eukaryotic ribosomes. FEBS Lett (1975) 0.99
Adenovirus late protein synthesis is resistant to the inhibition of translation induced by poliovirus. J Biol Chem (1987) 0.99
Modification of phospholipase C and phospholipase A2 activities during poliovirus infection. J Biol Chem (1989) 0.99
Cleavage of eukaryotic translation initiation factor 4G by exogenously added hybrid proteins containing poliovirus 2Apro in HeLa cells: effects on gene expression. Mol Cell Biol (1999) 0.98
Immunohistochemical characterization of hemangiopericytomas and other spindle cell tumors in the dog. Vet Pathol (1996) 0.98
Action of 3-methylquercetin on poliovirus RNA replication. J Virol (1987) 0.98
Membrane permeabilization by different regions of the human immunodeficiency virus type 1 transmembrane glycoprotein gp41. J Virol (1995) 0.98
A stable HeLa cell line that inducibly expresses poliovirus 2A(pro): effects on cellular and viral gene expression. J Virol (2000) 0.98
A poliovirus 2A(pro) mutant unable to cleave 3CD shows inefficient viral protein synthesis and transactivation defects. J Virol (1995) 0.98
Oestrogen and progesterone receptors in feline fibroadenomatous change: an immunohistochemical study. Res Vet Sci (2000) 0.97
Effects of ricin on the ribosomal sites involved in the interaction of the elongation factors. Eur J Biochem (1975) 0.97
Association between multiple sclerosis and Candida species: evidence from a case-control study. Eur J Clin Microbiol Infect Dis (2010) 0.96
Modification of membrane permeability during Semliki Forest virus infection. Virology (1985) 0.96
Specific proteins synthesized during the viral lytic cycle in vaccinia virus-infected HeLa cells: analysis by high-resolution, two-dimensional gel electrophoresis. J Virol (1986) 0.95
Molecular bases for the action and selectivity of nucleoside antibiotics. Med Res Rev (1984) 0.95
Entry of Semliki forest virus into cells: effects of concanamycin A and nigericin on viral membrane fusion and infection. Virology (1997) 0.94
Experimental African swine fever: apoptosis of lymphocytes and virus replication in other cells. J Gen Virol (1995) 0.93
Sindbis virus variant with a deletion in the 6K gene shows defects in glycoprotein processing and trafficking: lack of complementation by a wild-type 6K gene in trans. J Virol (2001) 0.93
Screening for new compounds with antiherpes activity. Antiviral Res (1984) 0.93
Brefeldin A blocks protein glycosylation and RNA replication of vesicular stomatitis virus. FEBS Lett (1993) 0.93
Antiviral activity of Bolivian plant extracts. Gen Pharmacol (1999) 0.93
Molecular biology of animal virus infection. Pharmacol Ther (1980) 0.92
Poliovirus induces apoptosis in the human U937 promonocytic cell line. Virology (2000) 0.92
Effects of fatty acids on lipid synthesis and viral RNA replication in poliovirus-infected cells. Virology (1991) 0.92
Cytokine expression by macrophages in the lung of pigs infected with the porcine reproductive and respiratory syndrome virus. J Comp Pathol (2009) 0.92
Inhibitors of poliovirus uncoating efficiently block the early membrane permeabilization induced by virus particles. J Virol (1991) 0.92
The elongation steps in protein synthesis by eukaryotic ribosomes: effects of antibiotics. Methods Enzymol (1974) 0.92
Mechanism of inhibition of HSV-1 replication by tumor necrosis factor and interferon gamma. Virology (1991) 0.92
Strawberry glans penis: a rare manifestation of angiokeratomas involving the glans penis. Br J Dermatol (2000) 0.92
Acute phase response in porcine reproductive and respiratory syndrome virus infection. Comp Immunol Microbiol Infect Dis (2009) 0.92
Concanamycin A blocks influenza virus entry into cells under acidic conditions. FEBS Lett (1994) 0.91
Cleavage of p220 by purified poliovirus 2A(pro) in cell-free systems: effects on translation of capped and uncapped mRNAs. Biochemistry (1997) 0.91
Mutations in the hydrophobic domain of poliovirus protein 3AB abrogate its permeabilizing activity. FEBS Lett (1995) 0.90
Antirhinovirus compound 44,081 R.P. inhibits virus uncoating. Antimicrob Agents Chemother (1986) 0.90
Expression of poliovirus 2Apro in mammalian cells: effects on translation. FEBS Lett (1995) 0.90
Pathology of AA amyloidosis in domestic sheep and goats. Vet Pathol (2003) 0.90
Reversion by hypotonic medium of the shutoff of protein synthesis induced by encephalomyocarditis virus. J Virol (1981) 0.90
Effects of poliovirus 2A(pro) on vaccinia virus gene expression. Eur J Biochem (1995) 0.90
Post-translational modifications of poliovirus proteins. Biochem Biophys Res Commun (1989) 0.89